MERLI, PIETRO
 Distribuzione geografica
Continente #
AS - Asia 48
NA - Nord America 46
EU - Europa 39
SA - Sud America 4
AF - Africa 1
Totale 138
Nazione #
US - Stati Uniti d'America 44
SG - Singapore 25
RU - Federazione Russa 18
IT - Italia 12
VN - Vietnam 8
CN - Cina 6
DE - Germania 3
FI - Finlandia 3
HK - Hong Kong 3
BD - Bangladesh 2
CA - Canada 2
JP - Giappone 2
AR - Argentina 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
FR - Francia 1
GB - Regno Unito 1
PY - Paraguay 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
Totale 138
Città #
Singapore 13
San Jose 10
Frisco 7
Santa Clara 5
Ashburn 3
Ho Chi Minh City 3
Hong Kong 3
Moscow 3
Rome 3
Turku 3
Beijing 2
Hanoi 2
Milan 2
Naples 2
New York 2
The Dalles 2
Ankara 1
Asunción 1
Baltimore 1
Ben Arous 1
Brussels 1
Catamarca 1
Chicago 1
Dammam 1
Falkenstein 1
Fortaleza 1
Frankfurt am Main 1
Giugliano in Campania 1
Guiyang 1
Haiphong 1
Hakozaki 1
Hefei 1
Lauterbourg 1
London 1
Los Angeles 1
Luoyang 1
Munich 1
Phoenix 1
Pittsburgh 1
Quận Bình Thạnh 1
Redondo Beach 1
San Bernardo 1
Sherwood Park 1
Staten Island 1
Tokyo 1
Toronto 1
Totale 95
Nome #
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 124
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 5
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial 4
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies 3
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 3
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases 3
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 2
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia 2
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 2
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 2
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts 1
Totale 151
Categoria #
all - tutte 529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202545 0 7 1 0 3 4 3 3 4 2 15 3
2025/2026106 10 5 8 8 13 5 8 2 10 6 29 2
Totale 151